Reports that U.S. small biotechnology companies are more intent on turning federal grants into patents, licenses and product introductions than larger companies according to a study by Department of Commerce's National Institute of Standards and Technology. Allocation of grants to companies from Advanced Technology Program (ATP); Criticism about allocation of funds from ATP; Importance of ATP funding.